This is the public record of open-market stock transactions Rhea J. Posedel has reported to the SEC on Form 4 as Director of AEHR TEST SYSTEMS (AEHR). Every figure below is the reported share count multiplied by the reported price, so the dollar amounts are exact disclosed values rather than estimates. It is a record of what has been filed, not a portfolio or a recommendation, and insider selling in particular is routine and rarely a signal on its own.
All 8 disclosed transactions, newest filing first.
How many shares has Rhea J. Posedel bought and sold?
Rhea J. Posedel has disclosed 8 Form 4 transactions in the record we track, from Feb 13, 2026 to Aug 12, 2026: 8 sales worth $8,712,953 and no open-market purchases. Each figure is the reported share count multiplied by the reported price, so these are exact disclosed amounts, not estimates.
Is Rhea J. Posedel selling a bearish signal?
Not on its own. Insiders sell for many reasons that have nothing to do with a view on the stock — diversification, taxes, estate planning, or a pre-scheduled plan set up months earlier. Of the 8 sales on this record, 0 were made under a Rule 10b5-1 plan and 0 were automatic tax withholding on vesting shares, leaving 8 that were the insider's own discretionary decision (worth $8,712,953). Buying is the cleaner signal, because there is only one reason to buy. This page is a record, not a recommendation.
What is Rhea J. Posedel's role?
Rhea J. Posedel files as Director of AEHR TEST SYSTEMS (AEHR). That role is taken from the Form 4 filings themselves. A Form 4 is filed with the SEC within two business days of an insider buying or selling their own company's stock.
What was Rhea J. Posedel's largest single transaction?
The largest single transaction on record is a sell of 30,000 shares of AEHR at $70.00, worth $2,100,000, filed Apr 10, 2026.
How current is this record?
The most recent Form 4 here was filed Aug 13, 2026. Insiders have two business days to file after a trade, so this is close to real time, but it is a record of what has been disclosed, not a statement of what Rhea J. Posedel currently holds. Amounts are open-market and plan transactions reported on Form 4; grants and option exercises are not counted as buys.
Source: Form 4 filings submitted to the SEC, the same public documents behind our insider trading tracker. Figures are open-market and plan transactions only; grants and option exercises are not counted as buys. A disclosure is not evidence of a market view, and none of this is investment advice. See the full AEHR stock page for price, filings and coverage.